Type 2 diabetes is being misdiagnosed in African-Americans, genetic study suggests

September 12, 2017, Wellcome Trust Sanger Institute
Credit: CC0 Public Domain

One of the tests used to diagnose type 2 diabetes and monitor blood sugar control is influenced by 60 genetic variants, an international team of scientists, including those from the Wellcome Trust Sanger Institute, has found. One genetic variant in particular, found only in African Americans, significantly reduces the accuracy of the HbA1c blood test used to diagnose and monitor the condition. This means around 650,000 African Americans in the US could have undiagnosed type 2 diabetes if tested with the HbA1c test alone.

The results, published today (12 September) in PLOS Medicine suggest screening for the particular genetic alongside the diagnostic , or using other in populations with African ancestry in order to improve diagnoses of type 2 diabetes.

There are over 4 million people living with diabetes in the UK, and this number is estimated to rise to 5 million by 2025. Ninety per cent of these cases are type 2 diabetes, which is associated withincreasing rates of obesity. In the US, the number of people with diabetes is more than 29 million.

In the largest study of its kind, an international team of more than 200 scientists investigated genetic variants which are thought to affect the blood test used to diagnose and monitor type 2 diabetes, known as the glycated haemoglobin, or HbA1c test.

The team studied genetic variants in almost 160,000 people from European, African, East Asian and South Asian ancestries who were not known to have type 2 diabetes. Researchers discovered 60 genetic variants that influence the outcome of HbA1c tests, of which 42 variants were new.

One genetic variant in particular, in the G6PD gene, was found to significantly impact the results of the HbA1c test. The G6PD genetic variant is almost unique to people of African ancestry; around 11 per cent of African Americans carry at least one copy of this variant.

Dr Inês Barroso, joint lead author from the Wellcome Trust Sanger Institute, said: "The issue with the G6PD genetic variant is it artificially lowers the value of blood sugar in the HbA1c test, and can lead to under-diagnosis of people with type 2 diabetes. We estimate that if we tested all Americans for diabetes using the HbA1c test, we would miss type 2 diabetes in around 650,000 African Americans. However, the HbA1c test remains a suitable test for diagnosing and monitoring diabetes for the majority of people."

The HbA1c test measures the amount of glucose, or sugar that is carried by the red blood cells in the body, for the previous two to three months.

Dr Eleanor Wheeler, joint first author from the Wellcome Trust Sanger Institute, said: "The G6PD genetic variant shortens the three-month lifecycle of red blood cells. So in African Americans who have this variant, their don't live long enough to bind to the glucose in the . Therefore these people will have a lower level of HbA1c, which won't show as a positive result for type 2 diabetes."

Dr James Meigs, joint lead author from Massachusetts General Hospital and Harvard Medical School, said: "We now need further studies involving people of diverse ancestries to assess how diagnostic tests for diabetes should be altered to account for . In the meantime, an option would be to genetically screen African Americans for the G6PD variant alongside the HbA1c test in order to accurately diagnose type 2 diabetes, or use other diagnostic tests such as fasting glucose measurements. We suggest moving towards precision medicine to take people's genetics into account and improve diagnosis and monitoring for ."

Explore further: Children at risk of diabetes should be screened by HbA1C, oral glucose tolerance tests

More information: Eleanor Wheeler et al. (2017) Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis. PLOS Medicine. DOI: 10.1371/journal.pmed.1002383

Related Stories

Children at risk of diabetes should be screened by HbA1C, oral glucose tolerance tests

April 4, 2017
Doctors should add an oral glucose tolerance test (OGTT) to their hemoglobin A1C (HbA1C) when they screen high-risk children for prediabetes and diabetes, new research from South Korea suggests. The study results will be ...

Sickle cell trait may confound blood sugar readings among African-Americans

February 7, 2017
A new study in JAMA provides evidence that hemoglobin A1c (HbA1c), a common blood biomarker used to measure blood sugar over time, may not perform as accurately among African-Americans with sickle cell trait and could be ...

Continuous subcutaneous insulin infusion bests injections in T2DM

April 7, 2017
(HealthDay)—For patients with type 2 diabetes and hemoglobin A1c (HbA1c) >8 percent following multiple daily injections (MDI), continuous subcutaneous insulin infusion (CSII) is associated with a significantly greater reduction ...

Fasting plasma glucose, HbA1c linked to alzheimer's in T2DM

July 25, 2017
(HealthDay)—For patients with type 2 diabetes mellitus (T2DM), fasting plasma glucose (FPG) visit-to-visit variation, represented by the coefficient of variation (CV), and hemoglobin A1c (HbA1c) CV are independently associated ...

Combining tests leads to better prediabetes detection

November 30, 2015
Using a combination of two blood sugar tests rather than a single test would improve detection of prediabetes in American children and adults, according to a new study by researchers at the School of Public Health at Georgia ...

African-Americans respond better to first-line diabetes drug than whites

June 12, 2014
African Americans taking the diabetes drug metformin saw greater improvements in their blood sugar control than white individuals who were prescribed the same medication, according to a new study published in the Endocrine ...

Recommended for you

A novel insulin accelerant

October 17, 2018
Insulin levels rise after eating a meal, signaling uptake of circulating glucose by skeletal muscle. In individuals with diabetes this process is often impaired—a condition known as insulin resistance.

Fat tissue may play a crucial role in the progression of diabetes, challenging long established notions

October 12, 2018
A new study by Australian researchers, out today, is challenging what we know about the causes of diabetes. The new research points to fat tissue as a source of disease, and widens our understanding beyond the traditional ...

Does breastfeeding hormone protect against type 2 diabetes?

October 12, 2018
(HealthDay)—The hormone prolactin—most commonly associated with breastfeeding—may play a role in reducing the risk of type 2 diabetes, a new study suggests.

Markers of dairy fat consumption linked to lower risk of type two diabetes

October 10, 2018
Higher levels of biomarkers of dairy fat consumption are associated with a lower risk of developing type 2 diabetes, according to new research published today in PLOS Medicine. The study, in more than 60,000 adults, was undertaken ...

Planned intermittent fasting may help reverse type 2 diabetes, suggest doctors

October 10, 2018
Planned intermittent fasting may help to reverse type 2 diabetes, suggest doctors writing in the journal BMJ Case Reports after three patients in their care, who did this, were able to cut out the need for insulin treatment ...

New discovery restores insulin cell function in type 2 diabetes

October 8, 2018
By blocking a protein, VDAC1, in the insulin-producing beta cells, it is possible to restore their normal function in case of type 2 diabetes. In preclinical experiments, the researchers behind a new study have also shown ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

omegatalon
not rated yet Sep 12, 2017
If these individuals do not have Type II Diabetes then what is the cause of the high glucose levels in the individuals blood.
johnp
not rated yet Sep 12, 2017
As it says in, IIRC, paragraph 9 of the article, in those with the G6PD genetic variant the test under reports the amount of glucose because their red blood cells don't live long enough for the glucose to sufficiently bind to the cells thus leading to a false negative.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.